Segmedica Completes Navigating COVID-19 Patient Journey

Segmedica announced today the completion of a fourth syndicated COVID-19 study. This study is of value to all manufacturers working on COVID-19 vaccines and pharmacological solutions or are impacted by COVID-19 patients’ journey through the healthcare system. Built from up to the minute primary fieldwork with patients, caregivers, and HCPs, we document with video clips the detailed experience.